-+ 0.00%
-+ 0.00%
-+ 0.00%

ST Renfu (600079.SH) subsidiary fentanyl citrate injection obtained marketing approval in Germany

Zhitongcaijing·11/02/2026 08:41:10
Listen to the news

Zhitong Finance App News, ST Renfu (600079.SH) announced that the company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd., recently received a marketing license approval letter for fentanyl citrate injections approved and issued by the German Federal Institute for Drugs and Medical Devices (BfArM). Fentanyl citrate injections are narcotic analgesics. After obtaining marketing approval from the German BfArM, they can be sold in Germany, which will have a positive impact on the company's international business expansion.